Comparison of targeted metagenomics and IS-Pro methods for analysing the lung microbiome

Show simple item record

dc.contributor.author Goolam Mahomed, Tanweer
dc.contributor.author Peters, Remco P.H.
dc.contributor.author Pretorius, G.H.J.
dc.contributor.author Mahomed, A. Goolam
dc.contributor.author Ueckermann, Veronica
dc.contributor.author Kock, Marleen M.
dc.contributor.author Ehlers, Marthie Magdaleen
dc.date.accessioned 2022-02-09T08:25:06Z
dc.date.available 2022-02-09T08:25:06Z
dc.date.issued 2021-08-18
dc.description SUPPLEMENTARY MATERIAL: Table S1. Inclusion and exclusion criteria for COPD patients in this study. Table S2. Clinical characteristic of patients. Table S3. Comparison of the number of amplicons and operational taxonomic units for each sample for the targeted metagenomics and IS-Pro methods. Figure S1. Relative abundance of specific phyla in the sputum microbiome of COPD participants as detected by targeted metagenomics and IS-Pro methods (n = 23). The dots represent the different abundances of each sample, according to the different phyla. Phyla that are depicted with a single line on the y-axis were not present in any samples for that method. Figure S2. Bar plots showing the relative abundance of genera in the sputum microbiome of COPD participants as characterised by targeted metagenomics and IS-Pro methods (n = 23). The operational taxonomic units that could not be classified at a genus level are indicated as NA on the graph. Figure S3. The distribution of the unclassified operational taxonomic units (OTUs) at a class level of the sputum microbiome of COPD participants for targeted metagenomics and IS-Pro methods by phyla. At a class level, all the OTUs from targeted metagenomics could be classified. en_ZA
dc.description.abstract BACKGROUND : Targeted metagenomics and IS-Pro method are two of the many methods that have been used to study the microbiome. The two methods target different regions of the 16 S rRNA gene. The aim of this study was to compare targeted metagenomics and IS-Pro methods for the ability to discern the microbial composition of the lung microbiome of COPD patients. METHODS : Spontaneously expectorated sputum specimens were collected from COPD patients. Bacterial DNA was extracted and used for targeted metagenomics and IS-Pro method. The analysis was performed using QIIME2 (targeted metagenomics) and IS-Pro software (IS-Pro method). Additionally, a laboratory cost per isolate and time analysis was performed for each method. RESULTS : Statistically significant differences were observed in alpha diversity when targeted metagenomics and ISPro methods’ data were compared using the Shannon diversity measure (p-value = 0.0006) but not with the Simpson diversity measure (p-value = 0.84). Distinct clusters with no overlap between the two technologies were observed for beta diversity. Targeted metagenomics had a lower relative abundance of phyla, such as the Proteobacteria, and higher relative abundance of phyla, such as Firmicutes when compared to the IS-Pro method. Haemophilus, Prevotella and Streptococcus were most prevalent genera across both methods. Targeted metagenomics classified 23 % (144/631) of OTUs to a species level, whereas IS-Pro method classified 86 % (55/64) of OTUs to a species level. However, unclassified OTUs accounted for a higher relative abundance when using the ISPro method (35 %) compared to targeted metagenomics (5 %). The two methods performed comparably in terms of cost and time; however, the IS-Pro method was more user-friendly. CONCLUSIONS : It is essential to understand the value of different methods for characterisation of the microbiome. Targeted metagenomics and IS-Pro methods showed differences in ability in identifying and characterising OTUs, diversity and microbial composition of the lung microbiome. The IS-Pro method might miss relevant species and could inflate the abundance of Proteobacteria. However, the IS-Pro kit identified most of the important lung pathogens, such as Burkholderia and Pseudomonas and may work in a more diagnostics-orientated setting. Both methods were comparable in terms of cost and time; however, the IS-Pro method was easier to use. en_ZA
dc.description.department Internal Medicine en_ZA
dc.description.department Medical Microbiology en_ZA
dc.description.librarian am2022 en_ZA
dc.description.sponsorship National Health Laboratory Service of South Africa (NHLS) Research Trust en_ZA
dc.description.uri https://bmcmicrobiol.biomedcentral.com en_ZA
dc.identifier.citation Goolam Mahomed, T., Peters, R., Pretorius, G. et al. 2021, 'Comparison of targeted metagenomics and IS-Pro methods for analysing the lung microbiome', BMC Microbiology, vol. 21, art. 228, pp. 1-13. en_ZA
dc.identifier.issn 1471-2180 (online)
dc.identifier.other 10.1186/s12866-021-02288-x
dc.identifier.uri http://hdl.handle.net/2263/83698
dc.language.iso en en_ZA
dc.publisher BioMed Central en_ZA
dc.rights © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. en_ZA
dc.subject Targeted metagenomics en_ZA
dc.subject Microbiome en_ZA
dc.subject Chronic obstructive pulmonary disease (COPD) en_ZA
dc.subject Intergenic spacer profiling (IS-Pro) en_ZA
dc.subject Operational taxonomic unit (OTU) en_ZA
dc.title Comparison of targeted metagenomics and IS-Pro methods for analysing the lung microbiome en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record